Orally Inhaled Antiarrhythmic Therapy

InCarda is developing a new nebulization therapy for patients who experience symptomatic,
acute episodes of paroxysmal atrial fibrillation (PAF).

Actual Atrial Fibrillation Patients
Provide Feedback on Orally Inhaled Flecainide

Hear from actual Atrial Fibrillation (AFib) patients:

“The longer you stay in AFib, the harder it is to get off of AFib.”
Matthew, 71

“You get this terrible fear you are going to die suddenly…”
Lucy, 73

“I’m just terrified, this is going to bring on the big heart attack…”
Andy, 58

Actual AFib Patients React to Orally Inhaled Flecainide

Actual Atrial Fibrillation (AFib) patients provide feedback on the Orally Inhaled Flecainide product concept.
Learn More